Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy. (Q34497376)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy. |
scientific article |
Statements
Novel GC-rich DNA-binding compound produced by a genetically engineered mutant of the mithramycin producer Streptomyces argillaceus exhibits improved transcriptional repressor activity: implications for cancer therapy (English)
Veronica Albertini
Aklank Jain
Sara Vignati
Sara Napoli
Andrea Rinaldi
Ivo Kwee
Mohammad Nur-e-Alam
Julia Bergant
Giuseppina M Carbone
Jürgen Rohr
Carlo V Catapano
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference